Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal imbalances are a key cause of missed menstrual periods in women.

Panchkarma treatment can help manage symptoms of Systemic Lupus Erythematous.

Oral ulcers are common in SLE patients and often link to other symptoms.

Oral contraceptives with desogestrel and drospirenone improve PCOS symptoms.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

The minoxidil-finasteride combination is more effective for hair growth than minoxidil alone.

Activated PRP effectively increases hair density and reduces hair loss in alopecia.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

Early identification of lupus through skin signs and blood tests is crucial in India.

Hormonal treatments effectively manage acne in some women, especially with specific hormonal issues.

The article concludes that hormonal therapy is an effective long-term acne treatment, even for those without hormonal imbalances.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Biomedical engineers are crucial for developing better treatments for chronic and autoimmune diseases.

Adiponectin and bradykinin play important roles in skin health and may help treat skin conditions.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Adults with certain skin conditions may have higher levels of inflammation in their body.